Introducing TrialNet Pathway to Prevention Study Chair Laura Jacobsen, MD
Pathway to Prevention Study Chair Laura Jacobsen, MD, is an assistant professor and pediatric endocrinologist at the University of Florida, Gainesville.
Making the time for T1D research — The Ebner Family, Monroe, Connecticut
With four boys who are active in multiple sports, the Ebners are a busy family. But when one of the Ebner sons was diagnosed with type 1 diabetes (T1D), the family made the time for T1D research.
Groundbreaking study finds JAK inhibitor baricitinib slows type 1 diabetes progression
World-first study findings by Australian researchers show a daily pill containing the JAK inhibitor baricitinib can preserve insulin production in people newly diagnosed with T1D. Published in the December issue of the New England Journal of Medicine, findings were co-authored by Thomas Kay, MBBS, PhD, and Helen Thomas, PhD, St.
Sign up here to join our mailing list for the latest updates on important T1D research and events, straight to your inbox. You can also find us on Facebook @DiabetesTrialNet.